Skip to main content
. Author manuscript; available in PMC: 2013 Apr 19.
Published in final edited form as: Mol Immunol. 2012 Aug 18;53(0):132–139. doi: 10.1016/j.molimm.2012.07.012

Fig. 2.

Fig. 2

Δ8-22 derivative activity in the hemolytic assay. (A) Peptide sequences. (B) Hemolytic assays performed with Δ8-22, alanine substitution peptides, internal control peptides sequences (ICS 1 and 2), and polar assortant (PA). The final concentration of peptide in serum was 0.77 mM. Values are the means of three independent experiments. Error bars represent the SEM. Experiments were performed with Factor B-depleted serum.